Display options
Share it on
Full text links
Atypon Free PMC Article

Mol Cell Biol. 1990 Dec;10(12):6426-35. doi: 10.1128/mcb.10.12.6426-6435.1990.

The SCL gene is formed from a transcriptionally complex locus.

Molecular and cellular biology

P D Aplan, C G Begley, V Bertness, M Nussmeier, A Ezquerra, J Coligan, I R Kirsch

Affiliations

  1. Navy Medical Branch, National Cancer Institute, Bethesda, Maryland 20814.

PMID: 2247063 PMCID: PMC362919 DOI: 10.1128/mcb.10.12.6426-6435.1990
Free PMC Article

Abstract

We describe the structural organization of the human SCL gene, a helix-loop-helix family member which we believe plays a fundamental role in hematopoietic differentiation. The SCL locus is composed of eight exons distributed over 16 kb. SCL shows a pattern of expression quite restricted to early hematopoietic tissues, although in malignant states expression of the gene may be somewhat extended into later developmental stages. A detailed analysis of the transcript(s) arising from the SCL locus revealed that (i) the 5' noncoding portion of the SCL transcript, which resides within a CpG island, has a complex pattern of alternative exon utilization as well as two distinct transcription initiation sites; (ii) the 5' portions of the SCL transcript contain features that suggest a possible regulatory role for these segments; (iii) the pattern of utilization of the 5' exons is cell lineage dependent; and (iv) all of the currently studied chromosomal aberrations that affect the SCL locus either structurally or functionally eliminate the normal 5' transcription initiation sites. These data suggest that the SCL gene, and specifically its 5' region, may be a target for regulatory interactions during early hematopoietic development.

References

  1. Science. 1980 Sep 19;209(4463):1406-14 - PubMed
  2. Genes Chromosomes Cancer. 1990 Jan;1(3):194-208 - PubMed
  3. Cell. 1983 Jun;33(2):501-8 - PubMed
  4. Proc Natl Acad Sci U S A. 1984 Jan;81(1):253-7 - PubMed
  5. Leuk Res. 1984;8(2):197-206 - PubMed
  6. Cell. 1983 May;33(1):125-33 - PubMed
  7. Cancer Genet Cytogenet. 1985 Oct;18(2):159-71 - PubMed
  8. Science. 1989 Jul 28;245(4916):371-8 - PubMed
  9. Cell. 1989 Aug 11;58(3):537-44 - PubMed
  10. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7103-7 - PubMed
  11. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10128-32 - PubMed
  12. J Exp Med. 1990 Jan 1;171(1):75-83 - PubMed
  13. J Exp Med. 1985 Nov 1;162(5):1561-78 - PubMed
  14. Cell. 1986 Jan 31;44(2):283-92 - PubMed
  15. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670-4 - PubMed
  16. Cell. 1986 Aug 29;46(5):659-67 - PubMed
  17. Nucleic Acids Res. 1987 Oct 26;15(20):8125-48 - PubMed
  18. Nature. 1988 Mar 10;332(6160):171-3 - PubMed
  19. Cell. 1988 Apr 8;53(1):3-4 - PubMed
  20. J Clin Invest. 1988 Sep;82(3):808-15 - PubMed
  21. J Immunol. 1988 Sep 15;141(6):2057-62 - PubMed
  22. J Biol Chem. 1988 Nov 25;263(33):17291-300 - PubMed
  23. Mol Cell Biol. 1988 Oct;8(10):4381-8 - PubMed
  24. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002 - PubMed
  25. Cell. 1989 Mar 10;56(5):777-83 - PubMed
  26. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2031-5 - PubMed
  27. Science. 1989 May 26;244(4907):943-50 - PubMed
  28. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5039-43 - PubMed
  29. Cell. 1989 Jul 14;58(1):77-83 - PubMed
  30. Cancer Res. 1968 Jun;28(6):1121-5 - PubMed
  31. Blood. 1975 Mar;45(3):321-34 - PubMed
  32. J Mol Biol. 1975 Nov 5;98(3):503-17 - PubMed
  33. Nature. 1977 Nov 24;270(5635):347-9 - PubMed
  34. EMBO J. 1990 Feb;9(2):415-24 - PubMed
  35. Cell. 1990 Mar 9;60(5):733-46 - PubMed
  36. Science. 1990 Mar 9;247(4947):1225-9 - PubMed
  37. Cell. 1990 Mar 23;60(6):909-20 - PubMed
  38. Cell. 1990 Apr 6;61(1):49-59 - PubMed
  39. Nature. 1990 Mar 29;344(6265):444-7 - PubMed
  40. Nature. 1990 Mar 29;344(6265):447-9 - PubMed
  41. Science. 1982 Jun 11;216(4551):1233-5 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources